Research graph
References from The mitophagy targeted nano-assemblies with high Salvianolic acid B -loading sufficiently enhances osteoarthritis therapy. Local targets link to admitted publications; unresolved targets remain external evidence.
Osteoarthritis
10.1038/s41572-025-00594-6 · 2025 · External reference
CircRREB1 mediates lipid metabolism related senescent phenotypes in chondrocytes through FASN post-translational modifications
10.1038/s41467-023-40975-7 · 2023 · External reference
Nanoengineered cargo with targeted in vivo Foxo3 gene editing modulated mitophagy of chondrocytes to alleviate osteoarthritis
10.1016/j.apsb.2024.12.008 · 2025 · External reference
Mitophagy in degenerative joint diseases
10.1080/15548627.2020.1822097 · 2021 · External reference
FUNDC1/PFKP-mediated mitophagy induced by KD025 ameliorates cartilage degeneration in osteoarthritis
10.1016/j.ymthe.2023.10.016 · 2023 · External reference
SIRT3-PINK1-PKM2 axis prevents osteoarthritis via mitochondrial renewal and metabolic switch
10.1038/s41413-025-00413-4 · 2025 · External reference
Chemical mitophagy modulators: drug development strategies and novel regulatory mechanisms
10.1016/j.phrs.2023.106835 · 2023 · External reference
Advances in the study of mitophagy in osteoarthritis
10.1631/jzus.b2300402 · 2024 · External reference
Mechanisms of mitophagy in cellular homeostasis, physiology and pathology
10.1038/s41556-018-0176-2 · 2018 · External reference
Mechano-metabolic dysregulation in osteoarthritis: piezo1-mediated mitophagy impairment as a novel therapeutic target
10.1007/s00011-025-02161-x · 2025 · External reference
Salvia miltiorrhiza bunge (danshen) based nano-delivery systems for anticancer therapeutics
10.1016/j.phymed.2024.155521 · 2024 · External reference
Intra-articular targeting of nanomaterials for the treatment of osteoarthritis
10.1016/j.actbio.2019.03.010 · 2019 · External reference
Current approaches of nanomedicines in the market and various stage of clinical translation
10.1016/j.apsb.2022.02.025 · 2022 · External reference
Berberine and magnolol exert cooperative effects on ulcerative colitis in mice by self-assembling into carrier-free nanostructures
10.1186/s12951-024-02804-x · 2024 · External reference
Co-assembled nanocomplexes comprising epigallocatechin gallate and berberine for enhanced antibacterial activity against multidrug resistant Staphylococcus aureus
10.1016/j.biopha.2023.114856 · 2023 · External reference
Brazilin-Ce nanoparticles attenuate inflammation by de/anti-phosphorylation of IKKβ
10.1016/j.biomaterials.2023.122466 · 2024 · External reference
Kidney-targeted antioxidant salvianolic acid B nanoparticles restoring lysosome homeostasis for acute kidney injury therapy
10.1016/j.cej.2024.151811 · 2024 · External reference
Pure drug nano-assemblies: a facile carrier-free nanoplatform for efficient cancer therapy
10.1016/j.apsb.2021.08.012 · 2022 · External reference
Role of molecular interactions in supramolecular polypeptide–polyphenol networks for engineering functional materials
10.1021/jacs.2c05052 · 2022 · External reference
Particle engineering enabled by polyphenol-mediated supramolecular networks
10.1038/s41467-020-18589-0 · 2020 · External reference
Supramolecular self-assembly of EGCG-Selenomethionine nanodrug for treating osteoarthritis
2024 · External reference
A sprayable TQ/Ce6@SAB/F-gel for accelerating wound healing via hypoxia-tolerant photodynamic therapy and immune–metabolic pathway
10.1016/j.biomaterials.2025.123602 · 2026 · External reference
Targeting the opening of mitochondrial permeability transition pores potentiates nanoparticle drug delivery and mitigates cancer metastasis
10.1002/advs.202002834 · 2020 · External reference
Selective metal–phenolic assembly from complex multicomponent mixtures
10.1021/acsami.9b04195 · 2019 · External reference
GROMACS: fast, flexible, and free
10.1002/jcc.20291 · 2005 · External reference
Mito-battery: micro-nanohydrogel microspheres for targeted regulation of cellular mitochondrial respiratory chain
10.1016/j.nantod.2023.101820 · 2023 · External reference
Efficacy and safety of curcumin therapy for knee osteoarthritis: a Bayesian network meta-analysis
10.1016/j.jep.2023.117493 · 2024 · External reference
Exploring the translational potential of PLGA nanoparticles for intra-articular rapamycin delivery in osteoarthritis therapy
10.1186/s12951-023-02118-4 · 2023 · External reference
Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects
10.1016/j.nantod.2014.04.008 · 2014 · External reference
Zwitterionic-based cyclic brush polymer nanomicelles with improved lubrication and antioxidation properties
10.1039/d5tb00704f · 2025 · External reference
Resveratrol-loaded biopolymer core-shell nanoparticles: bioavailability and anti-inflammatory effects
10.1039/d0fo00195c · 2020 · External reference
A natural polyphenolic nanoparticle--knotted hydrogel scavenger for osteoarthritis therapy
2025 · External reference
A composite hydrogel containing resveratrol-laden nanoparticles and platelet-derived extracellular vesicles promotes wound healing in diabetic mice
10.1016/j.actbio.2022.10.038 · 2022 · External reference
Amphiphilic poly(ethylene glycol)-cholesterol conjugate: stable micellar formulation for efficient loading and effective intracellular delivery of curcumin
10.1021/acsabm.4c01657 · 2025 · External reference
Intra-articular administration of PLGA resveratrol sustained-release nanoparticles attenuates the development of rat osteoarthritis, materials today
2024 · External reference
Hyaluronic acid modified curcumin-loaded chitosan nanoparticles inhibit chondrocyte apoptosis to attenuate osteoarthritis via upregulation of activator protein 1 and RUNX family transcription factor 2
10.1166/jbn.2022.3193 · 2022 · External reference
Novel natural carrier-free self-assembled nanoparticles for treatment of ulcerative colitis by balancing immune microenvironment and intestinal barrier
10.1002/adhm.202301826 · 2023 · External reference
A multifunctional biomimetic nanoplatform combined with immune checkpoint blockade for triple-negative breast cancer immunotherapy through inhibiting polarization of M2 macrophages
10.1186/s12951-025-03663-w · 2025 · External reference
